IMGN

Immunogen Inc

Delisted

IMGN was delisted on the 9th of February, 2024.

204 hedge funds and large institutions have $1.1B invested in Immunogen Inc in 2018 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 59 increasing their positions, 69 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

14% less repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 69

68% less call options, than puts

Call options by funds: $8.85M | Put options by funds: $27.5M

Holders
204
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$8.85M
Puts
$27.5M
Net Calls
Net Calls Change

Top Buyers

1 +$57.9M
2 +$39.1M
3 +$17.6M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$9.36M
5
Goldman Sachs
Goldman Sachs
New York
+$7.34M

Top Sellers

1 -$16.4M
2 -$15.7M
3 -$14M
4
Millennium Management
Millennium Management
New York
-$13.8M
5
RG
Redmile Group
California
-$12.7M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$313K
102
$293K
103
$288K
104
$287K
105
$267K
106
$266K
107
$265K
108
$264K
109
$263K
110
$246K
111
$240K
112
$240K
113
$227K
114
$225K
115
$217K
116
$217K
117
$209K
118
$202K
119
$200K
120
$196K
121
$195K
122
$195K
123
$188K
124
$183K
125
$181K